It is reported that, in the basis of the 21 production companies a written explanation on the 11 production companies suspected of violations Price by controlling the pin for the interviews. Through interviews and communication, most companies have said that as soon as possible to correct the failure to timely and full delivery behavior, to ensure timely delivery price; there are still some enterprises to supply according to the price.

According to the notification documents show that the medical institutions of Liaoning Province medicines and medical supplies centralized procurement work leading group office (hereinafter referred to as the “Liaoning Province medicine procurement”) for study, has promised not punishment according to the bidding price in full supply; not the price for production enterprises, timely and full delivery according to in the Chinese medicine group Rongsheng Pharmaceutical Company Limited (hereinafter referred to as the “Chinese medicine volume”), Limited by Share Ltd (now Tianjin Pharmaceutical Group Xinzheng pharmaceutical Limited by Share Ltd, and then into the) Shanghai Xudong Haipu Pharmaceutical Company Limited (hereinafter referred to as “Xudong Haipu”), Shanghai Jia Huangpu Pharmaceutical Company Limited (hereinafter referred to as the “best luck Huangpu”), Guangzhou Baiyun Ming Hing Pharmaceutical Company Limited (hereinafter referred to as the “Ming Xing Pharmaceutical”) and other 5 enterprises to give a warning.
In November 7th, Liaoning Province medicine procurement related to the weekly Times reporter, the province has established a supply shortage of drugs warning system in March and April this year, all medical institutions in Liaoning Province, Liaoning Province, are available through the procurement platform, reporting to the situation of drug procurement.
“In the reporting process, the 5 production companies in Liaoning drug shortage, the shortage after we know, most of the reason is because the price of drugs, not in accordance with the bid price of the original supply enterprises in Liaoning, so the price cannot supply in accordance with the proposed warning.” The source told the weekly times reporter.
This involved Mingxing pharmaceutical is a company located in Guangzhou veteran pharmaceutical enterprises, the main products are (Qingkailing injection, capsules, oral liquid) and other products, is one of the earliest production enterprises of qingkailing.
It is worth noting that this is not the first time this year by Mingxing pharmaceutical regulatory authorities concerned.